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Background: Babesiosis is an emerging health risk in several parts of the world. However, little is known about the
prevalence of Babesia in malaria-endemic countries. The area along the China-Myanmar border in Yunnan is a main
endemic area of malaria in P.R. China, however, human infection with Babesia microti (B. microti) is not recognized
in this region, and its profile of co-infection is not yet clear.
Methods: To understand its profile of co-infections with B. microti, our investigation was undertaken in the
malaria-endemic area along the China-Myanmar border in Yunnan between April 2012 and June 2013. Four parasite
species, including B. microti, Plasmodium falciparum (P. falciparum), P. vivax, and P. malariae, were identified among
449 suspected febrile persons detected by nested polymerase chain reaction (PCR) assay based on small subunit
ribosomal ribonucleic acid (RNA) genes of B. microti and Plasmodium spp.
Results: Of all the collected samples from febrile patients, mono-infection with B. microti, P. vivax, P. falciparum,
and P. malariae accounted for 1.8% (8/449), 9.8% (44/449), 2.9% (13/449), and 0.2% (1/449), respectively. The rate
of mixed infections of B. microti with P. falciparum or P. vivax are both 0.2% (1/449), and mixed infections of
P. falciparum and P. vivax accounted for 1.1% (5/449).
Conclusions: This report supports the hypothesis that babesiosis caused by B. microti is emerging along the
China-Myanmar border in the Yunnan province, P.R. China, but it was ignored because of low parasitemia or
mixed infection with Plasmodium spp. More sensitive and specific diagnosis methods are needed to find the
rapid response mechanism of emergency for babesiosis and malaria co-prevalence areas.
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Background
Babesiosis is a typical zoonotic disease which is caused
by Babesia spp., tick-borne intraerythrocytic protozoan
parasites. The first definitive case of human babesiosis,
was documented in a Yugoslavian farmer in 1957 [1]. The* Correspondence: huw@fudan.edu.cn
1National Institute of Parasitic Diseases, Chinese Center for Disease Control
and Prevention, WHO Collaborating Centre for Malaria, Schistosomiasis and
Filariasis, Key Laboratory of Parasite & Vector Biology Ministry of Health,
Shanghai 200025, China
4Department of Microbiology and Microbial Engineering, School of Life
Science, Fudan University, Shanghai 200433, China
Full list of author information is available at the end of the article
© 2013 Zhou et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the orfirst case in an immunocompetent person was identified
on Nantucket Island, off the coast of Massachusetts, in
1969 [2]. In fact, the causative agent was Babesia microti,
and the vector was the Ixodes dammini tick (now referred
to as I. scapularis) [3]. Babesiosis is now classified as a
notifiable disease and is recognized as an emerging
health risk in several parts of the world [4], but little is
known about the its prevalence in malaria-endemic
countries, where misidentification as Plasmodium spp.
probably occurs (http://dpd.cdc.gov/dpdx/HTML/Babe
siosis.htm). In Asia, B. microti-like organisms have caused
illness in Japan, Taiwan, and mainland China [5-8]. In
Europe, a few human babesiosis cases have been attributed
to B. divergens, the cattle species transmitted by I. ricinus
[9-11]. Hundreds of human babesiosis cases in the
northeast and midwest United States have been attributedtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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reported in Africa, Australia, and South America [9,13,14].
Recently, co-infection of parasites in humans has been
noticed in many areas [15-17]. Human babesiosis has
sometimes been diagnosed initially as malaria because
of the similarity between the two diseases or the two
parasites [18,19]. Thus, it is likely that cases of human
babesiosis in countries in which malaria is endemic
have been overlooked or misdiagnosed as malaria. The
area along the China-Myanmar border in Yunnan has
been reported as a main endemic area of malaria in the
People’s Republic of China (P.R. China) [20,21], however
B. microti has not been recognized as being endemic in
this region in the past. Therefore, surveillance was carried
out between April 2012 and June 2013 on the presence
of B. microti from the patients’ blood as detected by
molecular tools collected in this area.
Methods
Study area and population
The area along the China-Myanmar border in Yunnan is
a main endemic area of malaria in China. The region is
hilly and covered largely by primary and secondary
rainforests. Inhabitants of the division are mainly rural
indigenous people. Besides working for the logging
industry in the surrounding jungles, inhabitants of the
Tengchong county in the Yunnan province are actively
involved in mining, farming, hunting, logging, and working
abroad in Myanmar but coming back frequently. The
population of the Tengchong county is served by a
general hospital, a polyclinic at the county’s Center for
Disease Control and Prevention (CDC), and 15 government
health clinics.
The study was reviewed and approved by the Ethics
Committee at the National Institute of Parasitic Diseases,
Chinese Center for Disease Control and Prevention. Four
hundred and forty-nine blood samples in people with
malaria-like symptoms were obtained between April 2012
and June 2013 in the area along the China-Myanmar
border in the Yunnan province of China. Written consent
was obtained from each person before blood samples
were obtained.
Blood samples
This survey was carried out on the population seeking
care at the Tengchong county CDC. During the study
period, finger-prick blood samples on filter paper from
449 febrile patients with malaria-like symptoms were
taken. The thick and thin blood films were stained with
Giemsa and examined by staff at the diagnostic laboratories
of the polyclinic and hospital.
A drop (20 μL-50 μL) of blood was placed directly on
a pre-marked filter paper. DNA was extracted from the
blood spots with QIAGEN (QIAamp DNA Blood MiniKit, Biosearch Technologies, Inc. USA) and all of the
positive samples were used for sequencing the small
subunit ribosomal RNA (SSU rRNA) of the parasites.SSU rRNA Sequence and phylogenetic analysis
After the screening of Plasmodium spp. infection by
microscopy, all the samples’ DNA templates for a nested
polymerase chain reaction (PCR) were prepared from
whole blood spots on the filter paper. Two microliters
of PCR product from each, amplified by Plasmodium
genus-specific primer pair rPLU1 and rPLU5, were
subjected to a second PCR amplification with species-
specific primer pairs rVIV1 and rVIV2 for P. vivax,
rFAL1 and rFAL2 for P. falciparum, rMAL1 and
rMAL2 for P. malariae, and rOVA1 and rOVA2 for
P. ovale [22]. B. microti-specific fragments of SSU
rRNA were amplified from the DNA extracted from all
the febrile patients by nested PCR with two sets of
B. microti-specific primers, Bab1-Bab4, and Bab2-Bab3
(B. microti detection PCR), in accordance with the method
established by Persing et al. [23]. For B. microti detection
PCR-positive samples, a more accurate analysis by
amplification of the full-sized sequence (~1.7 kb) encoding
the 18S rRNA gene of the Babesia parasite from the
patients was applied with the nested PCR primers to
confirm the infections. The first round primers were
Piro1F: 5’-CCATGCATGTCTWAGTAYAARCTTTTA-3’
and rRNA-3’: 5’-ATCCTTCYGCAGGTTCACCTAC-3’.
The second round primers were BablA: 5’-GTCTTAG
TATAAGCTTTTATACAGCG-3’ and Prio6R: 5’-CTCCT
TCCTY TAAGTGATAAGGTTCAC-3’, as described by
Medlin et al. [24,25]. PCR amplification for each sample
was done in a 50 μL reaction mixture containing 400 mM
each of deoxynucleoside triphosphates, 0.25 mM of
primer, ten to 100 ng of template DNA, and 2.5 U of
Taq DNA polymerase (TIANGEN Biochemical) in 50 ml
of the PCR buffer supplied together with the enzyme. PCR
amplification parameters were: 94°C for four minutes,
35 cycles at 94°C for 30 seconds, 55°C for one minute
and 72°C for 2 min, followed by a final extension for
ten minutes at 72°C. PCR products amplified with nested
primers were analyzed by agarose gelelectrophoresis.
DNA bands were removed from the gel, purified by
using the QIAquick Gel Extraction Kit (QIAGEN, Valencia,
CA, USA), and ligated to T-cloning vector (Invitrogen,
Carlsbad, CA, USA) according to protocols provided by
the manufacturers.
To avoid errors caused by contamination of PCR
products, DNA was extracted and divided into several
aliquots in a safety cabinet placed in a room in which
PCR products had never been treated. Detection and
confirmation of PCR assays were separately carried out
with the different aliquots.
Table 1 B. microti and Plasmodium spp. detection in
449 suspected febrile patients in the area along the
China-Myanmar border in the Yunnan province between
April 2012 and June 2013
Parasite No. (%) persons
B. microti 8 (1.8)
B. microti / P. vivax 1 (0.2)
B. microti / P. falciparum 1 (0.2)
P. vivax 44 (9.8)
P. falciparum 13 (2.9)
P. vivax / P. falciparum 5 (1.1)
P. malariae 1 (0.2)
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was confirmed by random basic local alignment search
tool analysis of sequences in GenBank (http://blast.
ncbi.nlm.nih.gov/). Phylogenetic relationships of unique
sequences amplified were constructed by using the
neighbor-joining method using MegAlign software
(DNASTAR, Inc. Madison, WI, USA).
Results
Detection of B. microti and Plasmodium spp.
Four species of parasites taking residence in human
erythrocyte (B. microti, P. falciparum, P. vivax, and
P. malariae) were identified in 449 suspected febrile
persons. Mono-infection with B. microti, P. vivax,
P. falciparum, or P. malariae accounted for 1.8% (8/449),
9.8% (44/449), 2.9% (13/449), and 0.2% (1/449), respect-
ively, of the total infections. The rate of mixed infections
of B. microti and P. falciparum or P. vivax were both
0.2% (1/449), and mixed infections of P. falciparum
and P. vivax accounted for 1.1% (5/449) (see Table 1
and Figure 1). The total prevalence of B. microti wasFigure 1 Infection rate of B. microti and Plasmodium spp. in 449 susp
border in the Yunnan province between April 2012 and June 2013.2.2% (10/449). One P. falciparum mono-infection case,
five P. vivax, and eight B. microti cases were detected
from microscopy screening negative samples. Two mixed
infection cases of B. microti co-infection with P. falciparum
or P. vivax were initially diagnosed as mono-infections of
Plasmodium spp. by microscopy screening.
SSU rRNA sequence and phylogenetic analysis
All the positive samples were sequenced. Sequence iden-
tity was confirmed by random basic local alignment
search tool analysis of sequences in GenBank (http://
blast.ncbi.nlm.nih.gov/). Novel sequences were deposited
in GenBank with accession nos. KF410824-KF410827.
Phylogenetic relationships of unique sequences amplified
by using nested primers with corresponding reference
sequences were constructed by using the neighbor-
joining method using MegAlign software (DNASTAR,
Inc. Madison, WI, USA). All sequences clustered with
reference sequences of B. microti were from different
countries or regions, which suggested that all sequences
were species specific. Phylogenetic analysis showed that
amplified products were species specific (see Figure 2).
Morphological characteristics
We observed the intro-erythrocytic cycle of the field
samples in Giemsa-stained blood films from individuals
that were identified by PCR as having B. microti infections.
Babesia species resemble P. falciparum, however, Babesia
spp. has several distinguishing features: the early
trophozoite stage of B. microti is smaller than that of
P. falciparum and the infected erythrocytes are without
any pigments. And the late stage of trophozoites is
pleomorphic and can be vacuolated. Ring forms of
B. microti appeared smaller than that of P. falciparum and
do not produce pigment (see Figure 3A), while earlyected febrile patients in the area along the China-Myanmar
Figure 2 Phylogenetic analysis of 18S small subunit SSU rRNA gene sequences of B. microti in the malaria-endemic area along the
China-Myanmar border in the Yunnan province, April 2012 to June 2013. Fragments of 18S SSU rRNA gene sequences of samples were
analyzed by aligning with published homologous sequences of B. microti from different countries or regions. A phylogenetic tree was
constructed on the basis of similarities by the MegAlign software (DNASTAR, Inc. Madison, WI, USA). Novel sequences identified in this study are
indicated in boldface. Scale bar indicates nucleotide substitutions per site.
Figure 3 Typical morphology of erythrocytic stages of B. microti in patients in the area along the China-Myanmar border in the
Yunnan province, P.R. China. Giemsa-stained thin blood films from field samples. A: Early trophozoite or ring form of P. falciparum and malaria
pigment was scattered in the infected erythrocytes. B: Ring forms of B. microti in one erythrocyte without pigment. C: Two ring forms take
residents in one erythrocyte D: Tetrads of merozoites that are arranged in a cross-like pattern (a so-called Maltese cross).
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Figure 4 Area along the China-Myanmar border in the Yunnan province, P.R. China (which is hilly, and largely covered by primary and
secondary rainforests) with babesiosis and malaria.
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pigment was scattered in the infected erythrocytes (see
Figure 3B). Occasionally, two trophozoites or ring forms
would take residence in one erythrocyte (see Figure 3C).
Tetrads of merozoites that are arranged in a cross-like
pattern (a so-called Maltese cross) being pathognomonic
for babesiosis can be seen (see Figure 3D).Epidemiological data, clinical history
The demographic details of ten babesiosis patients
detected by nested PCR from 449 individuals were
recalled. All of these individuals were from the afore-
mentioned study area (see Figure 4). The brief hospital
records and data for clinical presentation, and whether
outbound history was available, are shown in Table 2,
but the treatment and outcome was not available. All
of the patients were adults and complained of fever
with chills and rigor before admission to hospital. We
tracked two babesiosis cases as well and found that
both of them recalled multiple tick bites in the recent
past and also participated in outdoor activities in the
mountains. One patient had even received bloodTable 2 Demographic and clinical data for patients of
babesiosis at dates of admission, in the area along the
China-Myanmar border in the Yunnan province, April
2012 to June 2013
Demographic data (n = 10)
Age (years) 32.9 (8.2, 22–45)
Male gender 6 (60%)
Adults (>18 years) 10 (100%)
Clinical history and presentations (n = 10)
Temperature at admission (°C) 37.8 (0.82, 36.0-38.8)
Outbound history 6 (60%)
Duration of illness before admission (days) 6.2 (9.4, 1–32)
Fever, chill, and rigor 10 (100%)
Data shown as n (% of total), or mean (SD; range) unless otherwise stated.transfusion and blood products for treatment of renal-
malaria before because of infection of P. falciparum.
Discussion
Between 1931 and 1944, Hung S.L. et al. [26] reported
several human parasitemia in Chongqing, China, on
protozoa taking residents in human erythrocytes, which
was described as being similar to P. falciparum, but with
fundamental differences of smaller ring forms and no
pigments, and so it clearly indicated that it was Babesia
spp. infection. These reports came 13 years earlier than
the first case of human babesiosis was reported in a
Yugoslavian farmer in 1957 [1], and strongly suggested
that human Babesia spp. infection may have already
existed widely in P.R. China. In fact, Yunnan, Inner
Mongolia, Taiwan and Zhejiang, and other regions in
P.R. China also have sporadic human babesiosis cases
reported from 1984 to 2012 [5,8,27-30]. Sun Y et al.
[31] reported that a B. microti-like rodent parasite was
isolated from the tick, I. persulcatus, collected from the
northern forest area of Heilongjiang province, P.R. China.
Saito-Ito et al. [32] confirmed Babesia spp. infection
of the Kobe strain presented in rodents in Zhejiang,
Fujian, and Taiwan. But there are no reports of regional
popularity on human babesiosis especilly in these natural
foci areas in which Babesia spp. existed in the ticks or/and
other reservoir hosts. Our study supports the hypothesis
that human babesiosis caused by B. microti infection is
emerging in areas along the China-Myanmar border in
counties such as Tengchong in the Yunnan province, P.R.
China, but can be ignored because of mix infection with
Plasmodium spp. or low parasitemia.
Both Plasmodium and Babesia species are intraery-
throcytic protozoans and they elicit similar inflammatory
responses and clinical manifestations that differ markedly
in severity. Babesia spp. co-infection with P. falciparum
could not be ruled out in one case. The possibility of
co-infection with babesial and malarial agents was well
described in an infant from the Ivory Coast who was
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both agents was reported in another rhesus monkey
imported from Guangxi, P.R. China and the suspected
infection of B. microti-like originated from primate-
breeding facility [34]. Here, we detected two cases of
febrile patients who were co-infected with Plasmodium
spp. and Babesia spp. in malaria endemic area by
molecular survey – it was unclear what the dominant
parasite was and the microscopy detection of the parasite
species of co-infections cases seem more difficult. It
was reported that a rhesus monkey that was chronically
infected with B. microti was able to control infection
with P. cynomolgi better than naïve monkeys [35]. The
suppression of Plasmodium spp. infection after chronic
exposure to B. microti also warrants further investigation
of a possible protective role of Babesia spp. infection
on Plasmodium spp.
The new finding of mono-infection of Babesia and
co-infection of Babesia spp. and Plasmodium spp. in the
malaria-endemic area of the Tengchong county would
bring new challenges to the prevention and controlling of
these infectious diseases. It must also be noted that most
antimalarial drugs, such as chloroquine, mefloquine, and
artemisinin, have no effect on babesiosis [36]. Quinine
and clindamycin, the former of which is often used for
treatment of drug-resistant malaria, are the first-choice
drugs against babesiosis [4,37]. Therefore, babesiosis in
areas in which malaria is endemic might be misdiagnosed
as drug-resistant malaria. From this standpoint, the
identification of babesial parasite infection in the Yunnan
province, where malaria is endemic, seems to deserve
attention, considering that recent Asian cases of human
babesiosis emerged in P. R. China and Japan, where
B. microti-like parasites had earlier been identified in
rodents. The importance of this finding in human co-
infection of Babesia spp. and Plasmodium spp. is also
reflected in case therapy as treatment of malaria patients
depends on correct diagnosis of parasite species [38].
Ring forms of Babesia spp. may resemble those of
P. falciparum [9]. Artemisinin-based combination
therapies are the recommended first-line treatments of
falciparum malaria in all countries where malaria trans-
mitted. There are recent concerns that the efficacy of such
therapies has declined on the Thailand-Cambodian and
Thailand-Myanmar borders, historically sites of emerging
antimalarial-drug resistance [39,40]. The morphology
of P. falciparum and B. microti are similar especially in the
ring form stage which is the main intraerythrocyte of
both parasites so human Babesiosis may be misdiagnosed
as falciparum malaria in these malaria endemic areas.
Giving Artemisinin-based combination therapies to these
babesiosis patients due to misdiagnosis would undoubtedly
increase the pressure of artemisinin resistance in malaria-
transmitted areas.Conclusions
Babesiosis has sometimes been diagnosed initially as
malaria because of the similarity between the two
diseases, which is the main reason why it is difficult to
detect it in co-infections [41]. This report supports the
hypothesis that babesiosis caused by B. microti is emerging
along the China-Myanmar border in the Yunnan province,
P.R. China, but it was ignored because of low parasitemia
or mixed infection with Plasmodium spp. It’s crucial to
apply more sensitive and specific diagnosis methods to
set up rapid response mechanisms of emergency for the
important infectious diseases in babesiosis and malaria
syndemic areas, particularly in places which are weak
in surveillance and response systems [42].
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